Analyst Ratings News 17 October 2025

PubMatic (PUBM) Soars on Q3 Beat as Analysts Hike Targets to $20; AI & CTV Momentum in Focus — Nov. 11, 2025

As of 15:42 UTC on Nov. 11, PubMatic shares last traded around $10.40, up sharply intraday following last night’s earnings and a flurry of analyst target increases. Why PUBM is moving today Key numbers & operating highlights Third quarter (ended

11 November 2025

Siemens Energy Hits Record Highs as Analysts Boost Targets: How AI, Grid Demand and a Wind Turnaround Drive the Stock Rally

Siemens Energy Soars After Jefferies Upgrade to €134; Commerzbank Jumps on Deutsche Bank ‘Buy’ as DAX Closes +1.65% (Nov 10, 2025)

Published: Monday, 10 November 2025 German equities rallied to start the week, led by Siemens Energy and Commerzbank after fresh analyst upgrades propelled both stocks to the top of the DAX. The benchmark index finished up 1.65% at 23,959.99, aided

10 November 2025

Analyst Ratings · DAX Index · Financial News · Investment · Stock Market

Qualys (QLYS) Today — Nov 8, 2025: Analyst Upgrade Follows Q3 Beat; Guidance Raised as Stock Hovers Near $150

Qualys, Inc. (NASDAQ: QLYS) is ending the week with fresh analyst attention after posting a stronger‑than‑expected third quarter and raising full‑year guidance earlier this week. As of today, one outlet reports an upgrade to Buy while another highlights lifted EPS

8 November 2025

Analyst Ratings · Earnings Reports · Financial News · NASDAQ:QLYS · Stock Market · Technology Stocks

Breaking: Eos Energy & MN8 Secure Huge 750 MWh U.S. Battery Storage Deal – Are Stocks Set to Skyrocket?

Eos Energy (EOSE) News Today: Price Target Uplift, Fresh Downgrade, and 70% Warrant Surge — What’s Moving the Stock (Nov 8, 2025)

Updated: November 8, 2025 Key takeaways What’s new today (Nov. 8, 2025) Downgrade lands after the run-up. MarketBeat carried an alert that Wall Street Zen cut EOSE to “Sell” early Saturday, noting the stock’s sharp appreciation and summarizing the existing

8 November 2025

Analyst Ratings · Eos Energy · Financial Updates · Investment News · Stock Market

UnitedHealth Group Stock Surges Amid Analyst Upgrades: Is Wall Street Turning Bullish on UNH in 2025?

UnitedHealth (UNH) Premarket: Analysts Bullish on Comeback Despite 2025 Woes – What to Watch Nov. 3, 2025

UnitedHealth’s volatile 2025 has made UNH a headline story heading into Nov. 3 trading. After a surprise earnings miss in Q1 and a CEO shakeup this spring, UNH plunged to four-year lows. In late Oct. the turnaround narrative got a boost:

2 November 2025

Analyst Ratings · Financial News · Health Insurance · Investment Strategies · Stock Market

Visa (V) Stock Poised for a Surge? Crypto Pilot and Travel Deals Fuel Optimism

Visa Stock Jumps on Earnings Beat and Dividend Hike – Analysts Bullish on $400 Target

Visa’s Stock Rallies After Earnings and Dividend Hike Visa’s latest earnings report delivered plenty for investors to cheer. The company’s fiscal fourth-quarter results (for the quarter ended September 30, 2025) beat expectations on both the top and bottom line. Net

28 October 2025

Analyst Ratings · Dividend Investing · Earnings Reports · Financial News · NYSE:V · Stock Market

Clover Health (CLOV) Stock Soars 18% on Analyst Upgrades, Unusual Options Buzz

Stock Performance: Clover Health stock has been exceptionally volatile in mid‑October 2025. On Oct. 21 it jumped ~8.7% intraday to ~$3.20 marketbeat.com (from $2.92 prior close), and on Oct. 24 it spiked another ~18%, trading near $3.79 (from $3.20 close

24 October 2025

Analyst Ratings · Financial Analysis · Investment News · NASDAQ:CLOV · Options Trading · Stock Market

Sunrun (RUN) Stock Soars 5% to 12-Month High on Analyst Upgrades and Solar Incentives

Stock Rallies on Upbeat Sentiment On Oct. 21, 2025, Sunrun (Nasdaq: RUN) traded around $20.50, up about 5% intraday reuters.com. This surge followed news that Wall Street’s Citigroup had upgraded Sunrun to “Buy” with a $26 price target marketbeat.com. The

21 October 2025

Analyst Ratings · Investment News · NASDAQ:RUN · Renewable Energy · Solar Power · Stock Market

iBio Stock Surges on Bullish Analyst Calls and Obesity Drug Breakthroughs

IBIO Stock Price and Recent Volatility As of midday October 21, 2025, iBio’s stock (NASDAQ: IBIO) trades around $0.89 per share marketbeat.com. The price has been volatile in recent days. Last week, shares jumped over 20% in pre-market trading on

21 October 2025

Analyst Ratings · Biotech · Obesity Research · Pharmaceuticals · Stock News

Beam Therapeutics Stock Soars on FDA Backing – Analysts Forecast ~70% Upside

Ticker: Beam Therapeutics (NASDAQ: BEAM) globenewswire.com. – Price (Oct 21, 2025): ~$30 per share (about +17% recently) ts2.tech. – Sector: Biotechnology (precision gene editing) globenewswire.com. – Recent News: FDA granted Regenerative Medicine Advanced Therapy (RMAT) and Orphan Drug designations to

21 October 2025

Analyst Ratings · Biotechnology · Healthcare · Investment · NASDAQ:BEAM · Stock Market

SoFi’s Roller-Coaster Rally: Fintech Stock Soars 230% in 2025 – What’s Next for SOFI?

SoFi Stock Surges on Analyst Upgrade and $1.6 Trillion Fintech Opportunity

Stock Rebound After Volatile Weeks SoFi’s stock has been on a roller-coaster. After tripling in the past year, climbing from single-digit prices to a record ~$30 in late September, the fintech favorite hit turbulence ts2.tech. In the final weeks of

20 October 2025

Analyst Ratings · Financial News · Fintech · Investment · NASDAQ:SOFI · Stock Market

Gilead Sciences (GILD) Stock Soars on Patent Victory, HIV Breakthroughs, and Analyst Upgrades

Stock Jumps as Outlook Brightens Gilead’s share price has been on a tear in recent weeks, reaching new highs for 2025. By mid-day October 17, GILD was up about 4.7% to roughly $123 per share benzinga.com. Year-to-date, the stock has

17 October 2025

Analyst Ratings · Biotechnology · HIV Research · Patent News · Stock Market

Analyst Ratings News 17 October 2025 - 11 November 2025